<DOC>
	<DOCNO>NCT00437333</DOCNO>
	<brief_summary>Metformin insulin sensitize drug routinely use treatment anovulatory patient polycystic ovary syndrome ( PCOS ) . To date , metabolic effect long-term metformin administration know data available effect suspension . The purpose study evaluate effect metformin suspension insulin sensitivity PCOS patient .</brief_summary>
	<brief_title>Metformin Suspension Insulin Sensitivity</brief_title>
	<detailed_description>Thirty young normal-weight anovulatory PCOS woman enrol . The diagnosis PCOS base presence clinical [ Ferriman-Gallwey score ≥ 8 ] biochemical hyperandrogenism ( serum testosterone level ( &gt; 2 SD reference mean value ) chronic anovulation [ serum luteal progesterone ( P ) 2 ng/mL ) ] . Patients randomly allocate two group ( metformin placebo group ) use computer-software . Fifteen PCOS patient treat metformin dosage 1700 mg daily ( one tablet 850 mg twice daily ; metformin group ) , whereas 15 PCOS treat placebo table ( one tablet twice daily ; placebo group ) . The duration treatment 12 month . Patients instruct follow usual diet physical activity , use barrier contraception throughout study . The length frequency menstrual cycle , adverse experience ( AEs ) report daily diary . Each subject undergo follow-up visit ( six 12 month treatment start ) treatment ( six 12 month treatment withdrawal ) . At follow-up visit , subject operator perform clinical , hormonal , metabolic , insulin sensitivity assessment euglycemic hyperinsulinemic clamp .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Polycystic ovary syndrome ( use NIH criterion ) . Age &lt; 20 &gt; 30 year ; BMI high 25 low 18 ; Neoplastic , metabolic , hepatic , cardiovascular disorder concurrent medical illness ; Hypothyroidism , hyperprolactinemia , Cushing ’ syndrome , nonclassical congenital adrenal hyperplasia ; Current previous use oral contraceptive , glucocorticoid , antiandrogens , ovulation induction agent , antidiabetic antiobesity drug hormonal drug ; Intention start diet specific program physical activity .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Insulin sensitivity</keyword>
	<keyword>Insulin-sensitizing drug</keyword>
	<keyword>Metformin</keyword>
	<keyword>PCOS</keyword>
	<keyword>Treatment</keyword>
</DOC>